PhD Position: Synergizing Immune Effectors and Transcriptional Modulation for Enhanced Type-I Interferon Therapy in MPNs (m/f/d)

following PhD project: Myeloproliferative neoplasms (MPNs) are blood cancers that arise from mutated hematopoietic stem cells... persistence of malignant stem/progenitor cells. A clinically active p300/CREBBP inhibitor is currently in development...

Lugar: Mainz am Rhein, Rheinland-Pfalz | 19/02/2026 20:02:48 PM | Salario: S/. No Especificado | Empresa: International PhD Programme (IPP) Mainz
1